Wang Lao JI trademark dispute controversy again true or false contract mystery
of Guangzhou Pharmaceutical Corporation and jiaduobao trademark disputes is not stopped because the Court's decision.
told reporters in Guangzhou pharmaceutical, "jiaduobao to the press on July 13 on the so-called ' secret contract ', many altered and contradictory, suspected of fraud. Guangzhou pharmaceutical group, has reported the case to police. "
jiaduobao responded to reporters," Guangzhou pharmaceutical in the media have openly admitted that agreement exists, but now claims that several changes this agreement, suspected of forgery, inconsistency. "
insiders, drinks the summer selling season is not over yet, the battle will not end on both sides.
jiaduobao is accused of forging contracts
on August 7, the Guangzhou pharmaceutical (600332) (Guangzhou pharmaceutical company limited) statement said, its controlling shareholder, Guangzhou Pharmaceuticals Corporation ("Guangzhou Pharmaceutical Corporation") has received the China international economic and Trade Arbitration Commission, dated July 31, 2012 X20120416 Trademark license agreement to dispute notice of arbitration. According to the notice, Hongdao (Group) Limited has it with Guangzhou pharmaceutical group was signed on May 2, 2003, the controversy over the trademark license agreement application for arbitration to the China international economic and Trade Arbitration Commission.
jiaduobao to reporters on July 13, the media in particular on release of the trademark license agreement.
However, Guangzhou pharmaceutical group of the trademark license agreement itself raised an objection.
"jiaduobao to the press on July 13 on the so-called ' secret contract ', many altered and contradictory, suspected of fraud. Guangzhou pharmaceutical group, has reported the case to police. "August 2, Guang Yao held Wang Lao JI group two law firms press briefing for trademark rights, Guangzhou, Jinqiao baixin on law firm Ma Lijun to voice their questions.
Ma Lijun told journalists cited a contradictory place.
time is the signing of the agreement "May 2, 2003", but the agreement Home said "this trademark license agreement (the" agreement ") by and between signed in Guangzhou, China on May 2, 2000". Difference between before and after the time of signing for three years. In addition, the agreement uses the term not in accordance with payment terms of all.
Ma Lijun said the agreement with the Parties compared to the trademark license agreement signed on May 2, 2000, in addition to the agreement, 2nd. 4 be handwritten changes to the term of the license "from January 20, 2003 to January 19, 2013", and finally signed hand-written with the words "2003" two differences, the rest of the terms, structure, wording and even the punctuation marks are strikingly consistent.
"can be said that the agreement was signed on May 2, 2000 version of the human hand tamper. "Ma Lijun believes that previous contributions of the trademark license agreement terms and contradict the terms of the license, set forth the date and signing date contradicts itself contradictory material is the lack of tangible proof of the validity of the evidence should not be admissible.
against Guangzhou pharmaceutical in question, and the company responded to the reporter for the China economic times.
jiaduobao related head said, its July 13 show of trademark license agreement for both recognized of content and sealed signed confirmed, according to contract agreed, wide drug as trademark of record obligations people, ought to to national trademark Council application record, so, wide drug in national trademark Council application and was record, addition wide drug in 2008, and 2009 active to Government related sector issued related proved.
jiaduobao stressed that this agreement, jiaduobao has been submitted to the China international economic and Trade Arbitration Commission arbitration to apply for and be accepted, request for arbitration of Canton drug violations.
jiaduobao also said that on July 13, when jiaduobao after the release of the third contract, Guangzhou pharmaceutical in the media have openly admitted that agreement exists, but now claims that several changes this agreement, suspected of forgery, inconsistency.
of Guangzhou Pharmaceutical Corporation in a press conference on July 16, Ni Yidong, Deputy General Manager of Guangzhou pharmaceutical group on July 13 jiaduobao upon the recognition of the trademark license agreement. At that time, Ni Yidong, said that the specific contents are subject to the trademark license agreement trademark licensing agreement signed in Guangzhou on May 2, 2000 (master contract), as well as in Guangzhou on October 27, 2002 signed a supplementary agreement concerning implementation of the provisions of, this agreement is not a full contract.
, Ni Yidong said Guangzhou pharmaceutical group of the trademark license agreement is to authorize Hong Tao Group exceeded the trademark renewal contract, exclusively for registered trademark authorization at the State administration for industry and commerce.
why Canton drug and now believed that the written contract twisted into it?
in this regard, the broad prescription media explained that the recent in process against Guangzhou pharmaceutical in rights ', jiaduobao illegal production of products were seized, the business sector of the requirement to sell these products businesses engaged in the production of the relevant legal instruments. Subsequently, the jiaduobao sent the agreements served on the business sector. Meanwhile, departments of industry and Commerce of Guangzhou pharmaceutical provides relevant legal instruments, two legal instruments are compared to see the problem.
However, for the Protocol is used for a registered trademark authorization at the State administration for industry and commerce, Guangzhou pharmaceutical declined to give an answer at present.
called product by check
Guangzhou pharmaceutical and jiaduobao also in the products continue to rise.
on August 1, Guangzhou Pharmaceutical Corporation signed a contract with Government of Taizhou, the first red cans Wang Lao JI herbal tea production base in Taizhou. Meanwhile, jiaduobao red cans went to "hunt down" also continues.
broad prescription for the reporter, said on June 18, Guangzhou Pharmaceutical Corporation since you started activism, including Xiamen, Shenzhen, Shantou, Ningbo, Beijing, Fuzhou, Hangzhou, Wuxi, Changzhou, Nanchang over more than 10 cities, such as business and law enforcement investigation of jiaduobao tort Wang Lao JI herbal tea products.
, however, jiaduobao also started to Guangzhou pharmaceutical red canned Wang Lao JI herbal tea counter.
told reporters in jiaduobao, currently in fengcheng, Jiangxi, guiping, Guangxi, Gansu Lanzhou and Xinjiang kuitun and other business sectors have been suspected of unfair competition and violation of "right to add much treasure herbal tea with red canned package" Guangzhou pharmaceutical products distributor sales of "red canned Wang Lao JI herbal tea" seal up.
"both sides of the battle into next year when the first selling season, the Spring Festival, according to pattern in the market might not be able to stop on both sides. "Bogey Advisory Managing Director Gao Jianfeng told the China economic times, both sides battle for the industry and consumers will not have a direct negative impact, or even beneficial, but the widespread drug currently Foundry capacity more, its product quality can be guaranteed to be a problem.
Beijing Zhi future marketing Advisory Group Chairman Li Zhiqi accepted an interview with the China economic times, marketing experts also believe that current beverage sales season not yet over, jiaduobao and Guangzhou pharmaceutical battle will continue.
"endless fight on both sides, for dealers and consumers will be hurt. Attempt to confuse the consumer brand, leading to disorderly competition in the market, which also offered fakes a certain space and living soil. "Li Zhiqi said, is not in favor of endless battle on both sides, after all, losing the pair who also did not want to see.